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Abstract: 
We describe herein for the first time the formation and spectroscopic characterization of homogeneous 
oxyferrous complexes of the cytochrome P450 BM3 (CYP102) holoenzyme and heme domain (BMP) at —55 
°C using a 70/30 (v/v) glycerol/buffer cryosolvent. The choice of buffer is a crucial factor with Tris 
[tris(hydroxymethyl)aminomethane] buffer being significantly more effective than phosphate. The oxyferrous 
complexes have been characterized with magnetic circular dichroism spectroscopy and the resulting spectra 
compared to those of the more well-characterized oxyferrous cytochrome P450-CAM. The formation of a stable 
substrate-bound oxyferrous CYP BM3 holoenzyme, despite the fact that it has the necessary reducing 
equivalents for turnover, indicates that electron transfer from the flavin domain to the oxyferrous center is very 
slow at this temperature. The ability to prepare stable homogeneous oxyferrous derivatives of both BMP and the 
CYP BM3 holoenzyme will enable these species to be used as starting materials for mechanistic investigation of 
dioxygen activation. 
 
Keywords: 
Mono-oxygenase; Dioxygen activation; Oxyferrous heme iron; Magnetic circular dichroism; Cryoenzymology; 
Cysteinate-ligated heme iron; Cytochrome P450 BM3 
 
Article: 
The cytochrome P450 (P450) superfamily, consisting of cysteinate-ligated heme iron mono-oxygenases, is 
extensively distributed throughout the plant, animal, and microorganism kingdoms. The reactivity of this family 
covers a vast number of dioxygen activation reactions including hydroxylation of unactivated alkanes, 
epoxidation of olefins, and the conversion of aromatics to phenols and of sulfides to sulfoxides or sulfones [1–
3]. The crucial oxygen atom insertion process in P450 is initiated by the binding of dioxygen to the ferrous iron 
[4,5] to yield the oxyferrous enzyme (1), in resonance with the ferric superoxide (2) complex (Fig. 1). Single 
electron reduction then gives the peroxoferric state (3), followed by proton addition to generate the 
hydroperoxoferric species (4). Addition of a second proton releases a water molecule to yield the oxo-iron(IV)-
porphyrin radical cation state known as P450 compound I (5). 
 
Oxyferrous P450 is quite unstable and readily autooxidizes to form the ferric state and superoxide anion. The 
rate of this process in the best characterized (and most stable) oxyferrous P450 derivative, P450-CAM, is about 
0.01 s-¹ (t1/2 = ~69 s) at 25 °C [6]. The released superoxide 
 
disproportionates to generate hydrogen peroxide, a source of destructive hydroxyl radicals. 
 
The fatty acid hydroxylase from Bacillus megaterium, P450 BM3, is a self-sufficient class II P450 composed of 
a heme-binding domain (BMP) and a flavin domain that contains both FMN and FAD. The X-ray structure of 
the ferric heme iron in substrate-free BMP (Fig. 2) reveals an iron-cysteinate Fe–S bond of 2.25 Å [7,8]. The 
formation of substrate-free and -bound oxyferrous BMP has been previously reported [9,10]. However, the 
results described herein demonstrate that the previously reported oxyferrous derivatives were significantly 
contaminated with ferric protein formed by autooxidation. In the present study, we describe for the first time the 
formation of stable homogeneous oxyferrous complexes of both BMP and the P450 BM3 holoenzyme. The 
homogeneity of these derivatives is demonstrated by comparison of their magnetic circular dichroism (MCD) 
and electronic absorption (EA) spectra to those of the more thoroughly characterized oxyferrous adduct of 
P450-CAM [1 1]. The ability to prepare stable homogeneous oxyferrous BMP and P450 BM3 holoenzyme will 
enable these species to be used as starting materials for mechanistic studies of dioxygen activation. 
 
MATERIALS AND METHODS 
 
Materials. 
O2 gas was obtained from Matheson. Sodium dithionite, arachidonic acid, glycerol, and all other reagent grade 
chemicals were purchased from Aldrich or Sigma and used without further purification. Sodium dithionite was 
kept in a desiccator under N2 to maintain its effectiveness as a reductant. 
 
P450 BM3 heme domain and holoenzyme. 
The preparation and purification of P450 BM3, heme domain, and holoenzyme, from Escherichia coli clones 
containing plasmids for the respective proteins, has been described earlier [12,13]. The purified protein was 
stored at -70 °C in 300 mM Tris [tris(hydroxymethyl)aminomethane] buffer (pH 8.0). Concentrations of ferric 
BMP and the holoenzyme were determined using ε417.5 = 100 (ferric substrate-free) and ε418.5 = 110 mM
-1
 cm
-1
 
(ferric substrate-free), respectively [14,15], at 4 °C in a 70/30 (v/v) mixture of glycerol and 300 mM Tris buffer 
(pH 8.0). Buffer pH was measured at 4 °C in the absence of glycerol. 
 
Spectroscopic techniques. 
Electronic absorption (EA) spectra were recorded with a Varian-Cary 400 spectrophotometer (at ~4 °C) or a 
 
 
JASCO J600A spectropolarimeter (at 55°C). Magnetic circular dichroism (MCD) spectra were measured in a 
0.2 or 0.5 cm cuvette at a magnetic field of 1.41 T with the JASCO J600A spectropolarimeter as previously 
described [16]. The Jasco J600A spectropolarimeter is equipped for the simultaneous recording of both MCD or 
circular dichroism (CD) and EA (as transmission) spectra. Data manipulations (transmission to absorption 
conversion, baseline and natural CD subtraction, smoothing, and normalization) were conducted (see [16] for 
MCD data) with JASCO software. 
 
Preparation of oxyferrous complex. 
Oxyferrous complexes were generated at —50 to —60°C in a chest freezer in a mixed cryosolvent consisting of 
a 70/30 (v/v) mixture of glycerol and 300 mM Tris buffer (pH 8.0). The ferric enzyme was first reduced by 
microliter additions of a near minimal amount of Na2S2O4 (up to 0.5 mM from a 20 mg/mL stock) under N2 at 4 
°C in a sealed cuvette to generate deoxyferrous P450, followed by cooling to —50°C and then by thorough 
bubbling with pre-cooled O2. Upon further cooling to temperatures as low as —55 to —60 °C, the glycerol-
containing cryosolvent behaves like a semi-solid glass. 
 
RESULTS AND DISCUSSION 
 
Spectroscopic characterization of cytochrome P450 BM3 in the presence of the cryosolvent 
The electronic absorption (EA) spectral properties of cytochrome P450 BM3 were first examined in the 
presence of the cryosolvent consisting of a 70/30 (v/v) mixture of glycerol and 300 mM Tris buffer (pH 8.0). 
Addition of a slight excess of arachidonic acid substrate (55 µM) to the ferric P450 BM3 heme domain (BMP) 
(~50 µM) caused the partial displacement of the bound water molecule in the active site, generating a high-
spin/low-spin mixture. As seen in Fig. 3, the Soret EA peak shifted from ~417.5 nm to a double-hump envelope 
maximized at ~396 nm, due to the high-spin component, but still retained significant absorption under the 
original peak from the low-spin component. A new peak appeared at 647 nm that could be assigned to the high-
spin component [17]. The existence of a high-spin/low-spin equilibrium that depends on the substrate 
concentration is believed to be accompanied by rearrangements of pivotal water molecules and the hydrogen 
bond network in the active site region [18]. Similarly, with microsomal P450 2B4 in the presence of 
benzphetamine, a ―ternary‖ complex of ferric heme iron, substrate, and a water molecule bound directly to the 
heme iron is known to exist [19]. 
 
Interestingly, further addition of excess substrate (~6 mM) gave mostly low-spin complex (Fig. 3) with the 
Soret EA peak at ~416 nm, with the usual peaks in the visible region at ~532 and ~565 nm attributable to a low-
spin ferric heme center. The MCD spectrum of this species is shown in Fig. 4A. The spectrum is very similar to 
that previously reported for low-spin ferric P450-CAM [20] and consists of a moderately intense derivative-
shaped feature in the Soret region and a series of increasing intense MCD peaks at 450, 510, and 550 nm, 
followed by a somewhat more intense, but negative, feature (trough) at 573 nm. 
 
The EA and MCD spectra of the cytochrome P450 BM3 holoenzyme were generally similar to those of the 
corresponding BMP states, as illustrated with low-spin substrate-free ferric P450 BM3 holoenzyme (Figs. 4A 
and B). The presence of the flavin domain had a small effect on the EA spectrum (additional shoulder at ~475 
nm) and almost no effect on the MCD spectrum of the low-spin ferric holoenzyme compared to the parallel 
derivatives of ferric BMP. Similar results have been reported for neuronal nitric oxide synthase [21]. 
 
Spectroscopic characterization of the oxyferrous complex of the oxygenase domain of cytochrome P450 BM3 
(BMP) 
A variety of conditions were examined in order to optimize formation of oxyferrous P450 BM3. The best 
cryosolvent was found to be a 70/30 (v/v) mixture of glycerol and 
 
 
300 mM buffer (pH 8.0). The use of glycerol as the antifreeze solvent worked especially well since at 
temperatures as low as —55 to —60 °C, it behaved like a semi-solid glass. Because it has generally been found 
that substrate-bound oxyferrous P450 is more stable than the substrate-free complex [11], we examined various 
P450 BM3 substrates (arachidonic, lauric, and palmitic acids) and found that arachidonic acid had the most 
stabilizing effect. All attempts to prepare homogeneous oxyferrous BMP in the 70/30 cryosolvent mixture with 
300 mM potassium phosphate (pH 7.7) were unsuccessful (data not shown) due to rapid autoxidation of the 
unstable oxyferrous complex, even at such low temperatures as —55 to —60 °C. Fortunately, Tris buffer was 
found to have a strong stabilizing effect on the oxyferrous state of P450 BM3. 
 
Upon anaerobic reduction of the ferric arachidonic acid- bound BMP with sodium dithionite, the Soret EA peak 
at 417.5 nm shifted to 414 nm and a broad single peak appeared at 547 nm in a 70/30 (v/v) mixture of glycerol 
and 300 mM Tris buffer (pH 8.0) (Fig. 4B). The MCD spectrum of ferrous substrate-bound BMP at —55 °C 
had a sharp derivative-shaped component centered at 556 nm (Fig. 4A) that was likely due to a small amount of 
six-coordinate ferrous species, as we reported for ferrous substrate-free P450-CAM under similar conditions 
[11]. The addition of pre-cooled oxygen generated a stable oxyferrous BMP that had EA and MCD spectra that 
were similar to the corresponding spectra of oxyferrous P450-CAM (Fig. 5) [11]. Oxyferrous BMP had a Soret 
EA peak at 422 nm and a single peak in the visible region at 559 nm; it had a prominent MCD trough at 587 
nm. 
 
The EA spectrum of oxyferrous BMP in the absence and presence of the substrate has been reported using 
stopped flow-rapid scan spectroscopy in 100 mM Mops [3-(N-morpholino)propanesulfonic acid] buffer (pH 
7.0) at 15 °C by Ost et al. [22]. Because of rapid autooxidation of the oxyferrous complex (Soret EA peaks at 
423 nm for the substrate-free and 425 nm for the arachidonic acid-bound forms), under these conditions, it is 
clear that only a mixture of oxyferrous (≤75%) and ferric form was observed 
 
 
for the substrate-free state. At cryogenic temperatures (-25 °C, with 50% v/v ethylene glycol), less than 50% of 
the oxyferrous intermediate was seen by Bec et al. (estimated from Fig. 1 in [10]). 
 
Hemoglobin and myoglobin form very stable oxyferrous complexes and function as molecular oxygen carriers. 
It has long been known that the autoxidation of oxyhemoglobin is promoted by anions, including phosphate 
[23,24]. Consequently, the observation reported herein that the two oxyferrous cytochrome P450 BM3 
derivatives were much less stable in phosphate buffer is not surprising. In addition, the proximal ligand in 
globins is neutral histidine, a relatively poor electron donor compared to the thiolate proximal ligand found in 
all cytochrome P450 enzymes. The electronic ―push‖ [25] of the proximal thiolate ligand will convey more 
charge onto the dioxygen ligand [i.e., an increased ferric-superoxo (2) contribution]. It is reasonable to suggest 
that the cationic nitrogen component of the Tris buffer may provide some additional charge neutralizing effect 
to stabilize the oxygenated complexes of the heme environment. We have recently found this to be a general 
phenomenon for thiolate-ligated oxyferrous heme centers [26]. 
 
Spectroscopic characterization of oxyferrous complex of the holoenzyme of cytochrome P450 BM3 
Despite the fact that the P450 BM3 holoenzyme is composed of the heme-binding domain (BMP) and a flavin 
domain having both FMN and FAD bound, and therefore contains all of the necessary reducing equivalents for 
substrate turnover when totally reduced, we were able to generate a stable oxyferrous derivative at cryogenic 
temperatures. Fig. 5 shows the MCD and EA spectra of the arachidonic acid-bound BM3 holoenzyme at —55 
°C in a 70/30 mixture of glycerol and 300 mM Tris buffer (pH 8.0). The MCD and EA spectra of the oxyferrous 
holoenzyme are similar to those of oxyferrous BMP (see below). Further, the presence of the sharp MCD trough 
at —590 nm indicates that the both oxyferrous P450 BM3 species did not contain any significant amount of the 
ferric (autoxidized) enzyme, which has an equally sharp MCD trough at ~576 nm (Fig. 4A) that is clearly 
missing. In addition, the EA spectra of both oxyferrous BM3 derivatives have a single peak in the visible region 
[559 nm (BMP) and 560 nm (holoenzyme)] (Fig. 5) that is distinct from the pair of peaks at 533 and 567 nm 
seen in the visible region EA spectrum of the low-spin ferric enzyme (Fig. 4). The MCD spectrum of the 
substrate-bound oxyferrous BM3 holoenzyme is also similar to that of the camphor-bound oxy-P450-CAM, 
with the main difference being the presence of a broad trough at ~455 nm in the spectrum of the holoenzyme. 
The formation of a stable substrate-bound oxyferrous CYP BM3 holoenzyme, despite the fact that it has the 
necessary reducing equivalents for turnover, indicates that electron transfer from the flavin domain to the 
oxyferrous center is very slow at this temperature. 
 
Spectral comparison of the oxyferrous states of BMP and the P450 BM3 holoenzyme 
Fig. 5A shows the comparison of the MCD spectra of oxyferrous BMP with that of the oxyferrous holoenzyme 
of cytochrome P450 BM3. The minor spectral difference at 455 nm between the spectra of the oxyferrous 
complexes of arachidonic acid-bound BMP and holoenzyme could be due to the influence of the flavin domain 
on the active site of the holoenzyme. Both oxyferrous BMP and the oxyferrous holoenzyme have asymmetric 
derivative-shaped Soret features. Additional overall spectral similarities with minor differences can be seen in 
EA spectra (Fig. 5B) with Soret peaks at ~423 nm and visible maxima at ~560 nm. Therefore, it can be 
concluded that the flavin domain has only a minimal effect on the spectral properties of the oxyferrous 
intermediate. 
 
CONCLUSIONS 
 
Characterization of the chemical and physical properties of the oxygenated intermediate in the P450 catalytic 
cycle is very important in order to achieve a better understanding of the nature of the reaction mechanisms of 
the P450 mono-oxygenases. We have found that preparation of stable oxyferrous P450 BM3 complexes not 
only depends on the temperature and handling method, but, especially, on the choice of the buffer. Herein, we 
have successfully generated and characterized the homogeneous oxyferrous complex for both cytochrome P450 
BM3 oxygenase domain (BMP) as well as the oxyferrous state of the BM3 holoenzyme. Furthermore, we find 
that the flavin domain has only a minor influence on the spectral properties of the oxyferrous state. 
 
The ability to prepare stable homogeneous oxyferrous forms of both BMP and the CYP BM3 holoenzyme will 
enable these species to be used as starting materials for mechanistic investigation of dioxygen activation. In 
particular, the successful stabilization of an extremely unstable (in potassium phosphate buffer) oxyferrous state 
will make it possible to carry out `cryoreduction' [4,5] experiments to capture and characterize oxygenated 
intermediates in the P450 catalytic cycle (Fig. 1, 3 and 4). In addition, with the oxyferrous holoenzyme, which 
has all of the necessary reducing equivalents for turnover, it may be possible to directly follow turnover by EA 
spectroscopy by slowly raising the temperature to ―turn on‖ electron transfer. 
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